Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group.
ESMO Open. 2020 Aug;5(4):e000774. doi: 10.1136/esmoopen-2020-000774.
ESMO Open. 2020.
PMID: 32817060
Free PMC article.
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.
Rapti V, Moirogiorgou E, Koliou GA, Papadopoulou K, Binas I, Pentheroudakis G, Bafaloukos D, Bobos M, Chatzopoulos K, Chrisafi S, Christodoulou C, Nicolaou I, Sotiropoulou M, Magkou C, Koutras A, Papakostas P, Kotsakis A, Razis E, Psyrri A, Tryfonopoulos D, Pectasides D, Res E, Alexopoulos A, Kotoula V, Fountzilas G.
Rapti V, et al. Among authors: moirogiorgou e.
Oncol Lett. 2022 Jan;23(1):23. doi: 10.3892/ol.2021.13141. Epub 2021 Nov 17.
Oncol Lett. 2022.
PMID: 34868360
Free PMC article.
Item in Clipboard
Risk factors, pathological and phenotypic features of male breast cancer in Greece.
Tsoukalas N, Moirogiorgou E, Tolia M, Pistamaltzian N, Bournakis E, Papadimitriou K, Demiri S, Panopoulos C, Koumakis G, Efremidis A; Hellenic Society for the Study of Breast Cancer (HES-BRECA).
Tsoukalas N, et al. Among authors: moirogiorgou e.
Anticancer Res. 2014 Mar;34(3):1291-4.
Anticancer Res. 2014.
PMID: 24596375
Item in Clipboard
Cite
Cite